Farzad Mostashari weighs in on the future of MSSP and ACOs, and he offers the new administration some health reform advice.
What does a Trump presidency mean for healthcare organizations? Must-read articles from Oliver Wyman Health.
Although the details and timing of repeal-and-replace are as yet unknown, providers can still begin preparing for change.
Despite changing political winds, value-based initiatives are as relevant as ever. Read new analysis of the ACO market and insight into next, best moves.
Drawing on new Oliver Wyman research, Helen Leis offers insight into how government organizations and other stakeholders could better connect with vulnerable health consumers.
Six ways that the new generation of connective technologies can impact the industry and drive long-term value.
This year’s StartUp Health Festival during JP Morgan Healthcare Week convened entrepreneurs, investors, and a world leader.
The promise of digital is better, faster, cheaper; and if any industry needs better, faster, cheaper, it’s healthcare.
Whole-genome sequencing is available, but consumers aren’t demanding it. What’s missing? Contextual, actionable insights. Watch the video.
Oliver Wyman's Sam Glick shares what to expect at this year's JP Morgan Healthcare Conference.
Oliver Wyman’s Tom Robinson discusses the ins, outs, challenges, and opportunities of payer-provider partnerships.
What does 2017 hold for healthcare investments? Lisa Suennen makes her predictions for investment trends and surprises.
Why old-school payer-provider partnerships don’t cut it in today’s marketplace and a new kind of partnership is gaining hold.